MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-08-09 and 2026-11-07, public records show 6 signals for MADRIGAL PHARMACEUTICALS, INC.. Most notable: 2026-11-06: BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP (director) bought $23.1M of stock; 2026-11-06: BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP (director) bought $5.3M of stock; 2026-11-04: BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP (director) bought $3.7M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-11-07 from public records.
Signals, last 12 months
- Insider purchaseBAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP (director) bought $23.1M of stock
- Insider purchaseBAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP (director) bought $5.3M of stock
- Insider purchaseBAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP (director) bought $793k of stock
- Insider purchaseBAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP (director) bought $3.7M of stock
- Insider purchaseBAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP (director) bought $2.1M of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Large insider saleTaub Rebecca (director) sold $1.1M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.3M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.3M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.3M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.3M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.0M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $1.0M of stock
- Large insider saleTaub Rebecca (director) sold $1.1M of stock
- Large insider saleTaub Rebecca (director) sold $1.1M of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Large insider saleFRIEDMAN PAUL A (director) sold $4.0M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $4.0M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $3.1M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $3.1M of stock
- Large insider saleTaub Rebecca (director) sold $2.6M of stock
- Large insider saleTaub Rebecca (director) sold $2.4M of stock
- Large insider saleTaub Rebecca (director) sold $2.6M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $2.4M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $2.8M of stock
- Large insider saleFRIEDMAN PAUL A (director) sold $2.8M of stock
- Large insider saleTaub Rebecca (director) sold $2.1M of stock
- Large insider saleTaub Rebecca (director) sold $2.1M of stock
- Large insider saleTaub Rebecca (director) sold $1.7M of stock
- Large insider saleTaub Rebecca (director) sold $1.7M of stock
- Large insider saleSibold William John (director) sold $1.4M of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-11-06 | Kelley Shannon T | officer | S | 1,077 | 400 | $430,800 |
| 2026-11-06 | BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP | director | P | 2,000 | 396.61 | $793,220 |
| 2026-11-06 | BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP | director | P | 13,740 | 388.29 | $5,335,105 |
| 2026-11-06 | BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP | director | P | 60,400 | 383.02 | $23,134,106 |
| 2026-11-04 | BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP | director | P | 10,080 | 368.11 | $3,710,583 |
| 2026-11-04 | BAKER BROS. ADVISORS LP; Baker Bros. Advisors (GP) LLC; BAKER FELIX; BAKER JULIAN; 667, L.P.; Baker Brothers Life Sciences LP | director | P | 5,586 | 366.99 | $2,050,018 |
| 2026-09-11 | Sibold William John | director | S | 120 | 546.38 | $65,565 |
| 2026-09-11 | Sibold William John | director | S | 761 | 544.83 | $414,616 |
| 2026-09-11 | Sibold William John | director | S | 1,539 | 544.02 | $837,253 |
| 2026-09-11 | Sibold William John | director | S | 1,202 | 542.6 | $652,209 |
| 2026-09-11 | Sibold William John | director | S | 368 | 541.64 | $199,324 |
| 2026-09-11 | Sibold William John | director | S | 687 | 540.59 | $371,382 |
| 2026-09-11 | Sibold William John | director | S | 160 | 537.62 | $86,019 |
| 2026-09-11 | Sibold William John | director | S | 218 | 535.94 | $116,836 |
| 2026-09-11 | Sibold William John | director | S | 106 | 534.06 | $56,611 |
| 2026-09-11 | Sibold William John | director | S | 60 | 533.09 | $31,985 |
| 2026-09-09 | Sibold William John | director | S | 160 | 542.55 | $86,808 |
| 2026-09-09 | Sibold William John | director | S | 362 | 541.65 | $196,079 |
| 2026-09-09 | Sibold William John | director | S | 505 | 540.19 | $272,796 |
| 2026-09-09 | Sibold William John | director | S | 215 | 539.03 | $115,891 |
| 2026-09-09 | Sibold William John | director | S | 520 | 538.3 | $279,914 |
| 2026-09-09 | Sibold William John | director | S | 640 | 537.17 | $343,791 |
| 2026-09-09 | Sibold William John | director | S | 1,040 | 536.11 | $557,557 |
| 2026-09-09 | Sibold William John | director | S | 644 | 535.27 | $344,715 |
| 2026-09-09 | Sibold William John | director | S | 396 | 534.2 | $211,542 |
| 2026-09-09 | Sibold William John | director | S | 512 | 533.09 | $272,944 |
| 2026-09-09 | Sibold William John | director | S | 368 | 531.99 | $195,772 |
| 2026-09-09 | Sibold William John | director | S | 522 | 530.23 | $276,781 |
| 2026-09-09 | Sibold William John | director | S | 347 | 529.27 | $183,656 |
| 2026-09-09 | Sibold William John | director | S | 131 | 527.88 | $69,152 |
| 2026-08-17 | Kelley Shannon T | officer | S | 664 | 514.97 | $341,940 |
| 2026-08-15 | REED JOHN C | director | A | 647 | 0 | $0 |
| 2026-07-20 | Sibold William John | director | S | 140 | 542.75 | $75,984 |
| 2026-07-20 | Sibold William John | director | S | 110 | 543.79 | $59,817 |
| 2026-07-20 | Sibold William John | director | S | 545 | 544.71 | $296,869 |
| 2026-07-20 | Sibold William John | director | S | 275 | 545.71 | $150,070 |
| 2026-07-20 | Sibold William John | director | S | 269 | 547.08 | $147,164 |
| 2026-07-20 | Sibold William John | director | S | 680 | 547.7 | $372,435 |
| 2026-07-20 | Sibold William John | director | S | 47 | 548.87 | $25,797 |
| 2026-07-20 | Sibold William John | director | S | 153 | 550.01 | $84,152 |
| 2026-07-20 | Sibold William John | director | S | 1 | 550.72 | $551 |
| 2026-07-20 | Sibold William John | director | S | 280 | 555.05 | $155,414 |
| 2026-07-17 | Sibold William John | director | M | 50,000 | — | — |
| 2026-06-17 | Taub Rebecca | director | A | 454 | 0 | $0 |
| 2026-06-17 | Levy Richard S | director | A | 454 | 0 | $0 |
| 2026-06-17 | FOUSE JACQUALYN A | director | A | 454 | 0 | $0 |
| 2026-06-17 | Daly James M | director | A | 454 | 0 | $0 |
| 2026-06-17 | Brennan Daniel J. | director | A | 404 | 0 | $0 |
| 2026-06-17 | Baker Brothers Life Sciences LP | director | A | 908 | 0 | $0 |
| 2026-06-17 | Baker Brothers Life Sciences LP | director | A | 908 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.